DELFI Collaborates with Hospital System to Improve Lung Cancer Screening
OSF HealthCare will use DELFI’s FirstLook Lung blood test to enhance lung cancer screening rates and early detection efforts.
Read MorePosted by Andy Lundin | May 13, 2024 | Lung Cancer |
OSF HealthCare will use DELFI’s FirstLook Lung blood test to enhance lung cancer screening rates and early detection efforts.
Read MorePosted by Andy Lundin | Apr 16, 2024 | Lung Cancer |
CAP developed recommendations for testing immunotherapy biomarkers, such as PD-L1 and TM), in patients with NSCLC.
Read MorePosted by Andy Lundin | Apr 4, 2024 | Lung Cancer |
Nucleix will present data that demonstrates the potential of a PCR assay to accurately differentiate between small cell lung cancer subtypes.
Read MorePosted by Andy Lundin | Jan 23, 2024 | Lung Cancer |
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read MorePosted by Andy Lundin | Jan 5, 2024 | Lung Cancer |
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Read More